Hematology-Oncology Clinics of North America

Papers
(The median citation count of Hematology-Oncology Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver65
Conflict and Access to Health Care49
Managing First-Line Metastatic Renal Cell Carcinoma45
Forthcoming Issues44
Copyright44
Remote Telemonitoring and Telehealth in Surgical Oncology43
Insights into Renal Cell Carcinoma with Novel Imaging Approaches42
Contents39
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia39
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis34
Contemporary Management of Dermatofibrosarcoma Protuberans32
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia26
Treatment of High-Risk Gestational Trophoblastic Neoplasia23
Copyright22
Hematology/Oncology Clinics of North America21
Contributors20
Contributors18
Contents18
Copyright18
Advances in Gastric Cancer Surgical Management17
Future Directions for Gestational Trophoblastic Disease17
The Landscape of Personalized Medicine in Gynecologic Cancer17
From Molecular Match to Surgical Decision: Precision Oncology Through a Surgical Lens17
The Evolving Landscape of Drug Therapies for Sickle Cell Disease16
Advances in Immunotherapy in Esophagogastric Cancer15
Disparities in Breast Cancer Outcomes and How to Resolve Them15
Contents15
Contents15
Benefits and Harms of Interception and Early Detection of Cancer15
Advances in Surgical Techniques for Lung Cancer15
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer15
Foreword14
Advances in Systemic Therapy in Pancreatic Cancer14
Clinical Characteristics and Treatment of Histiocytic Disorders in Children14
Genomic Alterations in Langerhans Cell Histiocytosis14
Histiocytic Disorders in Pediatric and Adult Patients14
Emerging Therapies in β-Thalassemia13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes13
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas13
Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer12
Clinical Vignettes Part I12
Advances in Neuroblastoma and Wilms Tumor12
Liposarcoma12
Forthcoming Issues12
Transhepatic Biliary Intervention for Malignant Biliary Obstruction12
Forthcoming Issues12
Evaluation and Management of Bing–Neel Syndrome11
Skin Cancer Precursors11
Malignancies of the Upper Gastrointestinal Tract11
Genes as Medicine11
Hereditary Renal Cell Carcinoma Syndromes11
The Evolving Role of Surgery in Multimodal Cancer Care11
Copyright10
Contents10
New Developments in Myeloma10
Gestational Trophoblastic Neoplasia10
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities10
Patient-Reported Outcomes in Radiation Oncology10
Bispecific Antibodies in the Treatment of Multiple Myeloma10
Advances in the Surgical Management of Esophageal Cancer9
Forthcoming Issues9
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy9
Management of In-Transit Metastatic Melanoma9
High-Risk Non-Melanoma Skin Cancers9
Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?9
Contributors9
Evolution of Gene Therapy, Historical Perspective8
Heavy Ion Particle Therapy in Modern Day Radiation Oncology8
Forthcoming Issues8
Palliative Therapy for Liver and Biliary Neoplasms8
Copyright8
Local Control in Soft Tissue Sarcomas8
Contents8
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer7
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma7
Clinical Complications and Their Management7
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers7
Contents7
Radiation-Induced Tissue Regeneration7
Melanoma Brain Metastasis7
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases7
Copyright7
Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations7
Breast Cancer and Lifestyle Factors7
Breast Cancer in India7
Early Detection of Precursor Diseases of Multiple Myeloma6
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia6
FLASH Radiotherapy6
Hemophilia A/B6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma6
Contributors6
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy6
Immune-Pathogenesis of Myeloma6
Targeted Therapy Innovations for Melanoma6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?6
Education and Training Models for Remote Learning6
Copyright6
Advances in Cervical Cancer6
Early-Stage Hodgkin Lymphoma6
Impact of Clonal Heterogeneity in Multiple Myeloma6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies6
Ductal Carcinoma In Situ6
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma6
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing5
Contents5
Transarterial Therapy for Liver Tumors5
Contents5
Remembering the Contributions of Professor David J. Weatherall5
Pathogenic Mechanisms in Thalassemia I5
Sarcomas5
Contents5
Genetics and Genomics of Gestational Trophoblastic Disease5
Forthcoming Issues5
Renal Cell Cancer5
Management of Waldenström Macroglobulinemia in Limited-Resource Settings5
Pathogenic Mechanisms in Thalassemia II5
Surgery for Recurrent Ovarian Cancer5
Merkel Cell Carcinoma5
Contributors5
Approach to High-Risk Multiple Myeloma5
Regulatory Aspects of Gene Therapy4
Role of Radiation in Treatment of Renal Cell Carcinoma4
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)4
Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia4
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer4
Innovation and Emerging Technologies in Radiation Oncology4
Preface4
Chronic Lymphocytic Leukemia4
Waldenström Macroglobulinemia4
Debate4
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia4
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia4
Contents4
Ablative Therapies for Liver Tumors4
Gastrointestinal Cancer Precursor Conditions and Their Detection4
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity4
Cutaneous T-cell Lymphoma4
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors4
Contents4
Smoldering Multiple Myeloma4
Functional Radiosurgery in the Management of Cancer Pain4
Contents4
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?4
Emerging Role of Blood-based Biomarkers in Sarcomas3
Copyright3
Surgical Management of Gestational Trophoblastic Neoplasia3
Contents3
Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals3
Surgical Management of Neuroendocrine Tumor Liver Metastases3
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma3
Forthcoming Issues3
Role of Ovarian Suppression in Early Premenopausal Breast Cancer3
Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH)3
Contributors3
Role of Surgery in Metastatic Renal Cell Carcinoma3
Contents3
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer3
Forthcoming Issues3
Contributors3
First-Line Treatment of Driver-Negative Non–Small Cell Lung Cancer3
Contributors3
Contemporary Multimodal Management of Primary Retroperitoneal Sarcomas3
Forthcoming Issues3
Breast Cancer Pathology in the Era of Genomics3
Contents3
Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms3
Pathology of Liver and Biliary Neoplasms3
Contributors3
The Emerging Potential of Lead-212 Theranostics3
Patient, Caregiver, and Provider Well-Being in Oncology3
New Therapies on the Horizon3
Forthcoming Issues3
Subsequent Malignant Neoplasms in Childhood Cancer Survivors3
Copyright3
Escalation, De-escalation, Adaptation, Speciation, Customization: The New Approaches to Breast Cancer3
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia3
New Tools and Drugs Improve the Balance Between Cure and Toxicity in Hodgkin Lymphoma3
Advances and Opportunities in the Management of Lung Cancer3
Evolving Concepts in the Management of Desmoid Tumors3
Surgical Management of Genitourinary Cancer Liver Metastases3
Cervical Cancer2
Locally Advanced Lung Cancer2
Evidence-Based Guidance for Breast Cancer Survivorship2
Contents2
Macrophage Activation Syndrome2
Hematopoietic Stem Cell Transplantation in Thalassemia2
Updates on Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma2
Immunotherapy2
Artificial Intelligence, Machine Learning and Big Data in Radiation Oncology2
Resistance to Bruton Tyrosine Kinase Inhibitors2
Surgical Management of Colorectal Cancer Liver Metastases2
Innovations in Gynecologic Cancer Care2
Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases2
Impact of Social Media on Oncology Care2
Copyright2
Contributors2
Microbiome and Immunotherapy for Melanoma2
Contributors2
Copyright2
Lung Cancer2
Radiological Assessment of Liver and Biliary Neoplasms2
The Role of the Pathologist in Renal Cell Carcinoma Management2
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma2
Smart Solutions to Address the Global Gap in Radiation Oncology Through Trainee Engagement and Partnerships with Industry2
Copyright2
Gene Therapy for Inborn Errors of Immunity2
Radiotherapy for Pancreatic Adenocarcinoma2
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer2
Novel Targeted Therapies for Renal Cell Carcinoma2
Novel Immune Therapies for Renal Cell Carcinoma2
Cellular and Novel Immunotherapies for Classic Hodgkin Lymphoma2
Pathology of Gestational Trophoblastic Disease (GTD)2
Chimeric Antigen Receptor T-cell Therapy1
Contributors1
Systemic Therapy for Biliary and Liver Neoplasms1
Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care1
Sickle Cell Disease: New Approaches for an Old Disease1
Gene Therapy for Hemoglobinopathies1
Liver and Biliary Tract Cancers1
Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies?1
Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia1
The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma1
Clinical Vignettes, Part II: Eyes, Teeth, and Bone1
Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets1
Surgical Management of the Axilla for Breast Cancer1
Gastrointestinal Stromal Tumor1
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma1
Quality of Life in Sickle Cell Disease1
Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy1
Gene-Based Therapies for Pediatric Blood Diseases1
Triplet Therapies in Chronic Lymphocytic Leukemia1
Updates in Pediatric Oncology1
Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia1
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia1
Management of Locoregional Melanoma1
Contributors1
Contributors1
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease1
Cereblon-Targeting Ligase Degraders in Myeloma1
What Is New in Small Cell Lung Cancer1
Fighting Cancer in Ukraine at Times of War1
The Chronic Lymphocytic Leukemia Epigenome1
Copyright1
Lung Cancer Supportive Care and Symptom Management1
Structural Racism and Impact on Sickle Cell Disease1
Contents1
Biology and Treatment of HER2-Low Breast Cancer1
Nonsurgical Therapy for Early-Stage Lung Cancer1
Ultra High-risk Gestational Trophoblastic Neoplasia1
0.26089191436768